!, they will try to find out what is problem with the dead, this is most important, if they can,t or they find out it is big issue and the drug can't back to market, then they go to second step
2. they will try to sale the company or merge with other company, if can't , they go to step 3
3. consider bk.
so this is normal, and bk is far away now, but I don't understand why of the article title is 75% cut... BK...???
even 75%cut, they still have about 75 full time workers, that is large enough for a small bi-tech company (kerx only have 25 full time).
so i think 60% they can find out and fix the problem. $8 to $10
20% can sale or merge the company $3 to $5
20% BK 0